期刊文献+

DL-丁胱亚磺酰亚胺导致结肠癌细胞铁死亡的作用研究 被引量:5

Role of DL-buthionine-(S,R)-sulfoximine in ferroptosis of colon cancer cells
下载PDF
导出
摘要 目的:研究DL-丁胱亚磺酰亚胺(DL-BSO)导致结肠癌细胞发生铁死亡的作用机制。方法:(1)采用梯度浓度的DL-BSO干预人结肠癌HCT-116和SW480细胞,CCK-8法检测细胞活力的改变。(2)采用实验浓度的DL-BSO干预2种细胞,分为对照组和实验组,Transwell和划痕实验检测细胞迁移能力,Western blot法检测目的蛋白表达水平。(3)用necrostatin-1(Nec-1)和ferrostatin-1(Fer-1)预处理2种细胞,再用实验浓度的DL-BSO进行干预,分为对照组、DL-BSO组、抑制剂组和DL-BSO联合抑制剂组,CCK-8法检测细胞活力,以铁离子比色法试剂盒检测铁离子浓度,以谷胱甘肽(GSH)试剂盒检测GSH浓度,以Western blot法检测谷胱甘肽过氧化物酶4(GPX4)和胱氨酸/谷氨酸反向转运体(xCT)表达水平,以脂质过氧化传感器C11-BODIPY-591荧光显影和流式细胞术检测活性氧(ROS)水平。结果:DL-BSO干预后,HCT-116和SW480细胞活力均显著减弱,DL-BSO的最适浓度和处理时间分别为300μmol/L和36 h。DL-BSO处理使HCT-116和SW480细胞横向及纵向迁移能力均减弱,铁死亡关键蛋白GPX4和xCT表达下调,ROS水平和铁离子浓度升高,GSH浓度降低。DL-BSO的作用不受Nec-1的回调,但受到Fer-1的回调。结论:DL-BSO能通过铁死亡途径导致结肠癌细胞发生死亡,并减弱细胞的侵袭和迁移能力。 AIM:To investigate the mechanism of DL-buthionine-(S,R)-sulfoximine(DL-BSO)leading to ferroptosis of colon cancer cells.METHODS:(1)Human colon cancer HCT-116 and SW480 cells were treated with different concentrations of DL-BSO,and the cell viability was detected by CCK-8 assay.(2)The cells were treated with DLBSO at experimental concentration,and divided into control group and DL-BSO group.The cell migration ability was detected by Transwell and scratch assays,and the expression levels of the target proteins were detected by Western blot.(3)The cells were pretreated with necrostatin-1(Nec-1)or ferrostatin-1(Fer-1),intervened with DL-BSO at experimental concentration,and divided into control group,DL-BSO group,inhibitor group and DL-BSO combined inhibitor group.The cell viability was detected by CCK-8 assay,and the iron ion concentration was detected by colorimetry.The gluthione(GSH)level was determined by commercially available kits,and the glutathione peroxidase 4(GPX4)and cystine/glutamate antiporter(xCT)expression levels were detected by Western blot.The level of reactive oxygen species(ROS)was detected by lipid peroxidation sensor C11-BODIPY-591 fluorescence visualization and flow cytometry.RESULTS:After DL-BSO intervention,cell viability was significantly reduced,and the optimal concentration and treatment time of DLBSO were measured at 300μmol/L and 36 h,respectively.Cell lateral and longitudinal migration ability was also reduced.The expression of GPX4 and xCT,key proteins of ferroptosis,was down-regulated.The ROS level and iron ion concentration were increased,and GSH concentration was decreased.The effects of DL-BSO were counteracted by Fer-1 rather than Nec-1.CONCLUSION:Treatment with DL-BSO causes death of colon cancer cells through the ferroptosis pathway and diminish their invasion and migration ability.
作者 郑拥 孙玥 辛宝山 罗斌 刘刚 史良会 ZHENG Yong;SUN Yue;XIN Baoshan;LUO Bin;LIU Gang;SHI Lianghui(Department of Gastrointestinal Surgery,the First Affiliated Hospital of Wannan Medical College,Wuhu 241000,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2023年第8期1399-1407,共9页 Chinese Journal of Pathophysiology
基金 安徽省教育厅自然科学研究计划项目(No.2022AH051241) 皖南医学院中青年科研基金(No.WK2021F07)。
关键词 DL-丁胱亚磺酰亚胺 结肠癌 铁死亡 DL-buthionine-(S,R)-sulfoximine colon cancer ferroptosis
  • 相关文献

参考文献3

二级参考文献29

  • 1Ling Xue,Zhen Wu,Xiao-Ping Ji,Xia-Qing Gao,Yan-Hua Guo.Effect and mechanism of salvianolic acid B on the myocardial ischemiareperfusion injury in rats[J].Asian Pacific Journal of Tropical Medicine,2014,7(4):280-284. 被引量:24
  • 2Ferlay Jacques,Shin Hai-Rim,Bray Freddie,Forman David,Mathers Colin,Parkin Donald Maxwell.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Journal international du cancer . 2011
  • 3Wendy Atkin,Edward Dadswell,Kate Wooldrage,Ines Kralj-Hans,Christian von Wagner,Rob Edwards,Guiqing Yao,Clive Kay,David Burling,Omar Faiz,Julian Teare,Richard J Lilford,Dion Morton,Jane Wardle,Steve Halligan.Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial[J].The Lancet.2013
  • 4Waddell T,Verheij M,Allum W,Cunningham D,Cervantes A,Arnold D.Gastric cancer:ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis,treatment and follow-up. Annals of Oncology . 2013
  • 5J. Cubiella,M. Salve,M. Díaz‐Ondina,P. Vega,M. T. Alves,F. Iglesias,E. Sánchez,P. Macía,I. Blanco,L. Bujanda,J. Fernández‐Seara.Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria[J]. Colorectal Dis . 2014 (8)
  • 6Sigrun Losada Eskeland,Eirin Dalé,n,Jon Sponheim,Even Lind,Cathrine Brunborg,Thomas de Lange.European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy – a quality control study[J]. Scandinavian Journal of Gastroenterology . 2014 (4)
  • 7P. J. McDonald,J. Digby,C. Innes,J. A. Strachan,F. A. Carey,R. J. C. Steele,C. G. Fraser.Low faecal haemoglobin concentration potentially rules out significant colorectal disease[J]. Colorectal Dis . 2013 (3)
  • 8Fabrizio Parente,Barbara Marino,Antonina Ilardo,Pierluigi Fracasso,Angelo Zullo,Casare Hassan,Roberto Moretti,Marco Cremaschini,Antonio Ardizzoia,Ilaria Saracino,Federico Perna,Dino Vaira.A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study[J]. European Journal of Gastroenterology & Hepatology . 2012 (10)
  • 9Lidia Argüello,Virginia Pertejo,Marta Ponce,Salvador Peiró,Vicente Garrigues,Julio Ponce.The appropriateness of colonoscopies at a teaching hospital: magnitude, associated factors, and comparison of EPAGE and EPAGE-II criteria[J]. Gastrointestinal Endoscopy . 2012 (1)
  • 10R. J.Courtney,C. L.Paul,R. W.Sanson‐Fisher,F.Macrae,J.Attia,M.McEvoy.Current state of medical‐advice‐seeking behaviour for symptoms of colorectal cancer: determinants of failure and delay in medical consultation[J]. Colorectal Disease . 2012 (5)

共引文献19

同被引文献26

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部